Meet the young women unlocking new ways to treat diseases and shaping the future of medicine

In biotech, it's estimated that only about 7-9% of chief executive roles are filled by women. It's not an issue that's unique to drugmakers: Among the Fortune 500, 6.4% were led by female CEOs.

But among the generation of leaders under 40, there are a number of women who are building companies, unlocking new ways to treat cancer, and harnessing revolutionary gene-editing tools.

Business Insider intitially came up with a list of 30 leaders, through nominations and past coverage, who are shaping the future of medicine. Of that list, half were women. We asked them what the contribution the under-40 generation would have on medicine.

Here's who's doing groundbreaking work as young female leaders under 40 in biopharma, listed alphabetically.